What is the role of radionuclide scintigraphy in the workup of smoke inhalation injury?

Updated: Oct 15, 2021
  • Author: Keith A Lafferty, MD; Chief Editor: Joe Alcock, MD, MS  more...
  • Print

Delayed or inhomogeneous clearance of 133Xenon can be used to detect small-airway parenchymal injury. However, this study adds little to the clinical management and is not known to offer any particular therapeutic advantage. [44]

Likewise, increased clearance of aerosolized technetium-99m–labeled diethylenetriaminepentaacetate (99mTcDTPA) is a sensitive indicator of injury to the alveolar capillary membrane. However, its clinical use is not yet established.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!